Iterum Therapeutics Plc (ITRM)

$0.03 -0.04 (-57.39%)
Market Cap 1.60M
Revenue (ttm) 0.00
Net Income (ttm) -24.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.88
Volume 65,735,500
Avg Vol 19,797,338
Day's Range N/A - N/A
Shares Out 53.29M
Stochastic %K 2%
Beta 2.96
Analysts Hold
Price Target $9.00

Company Profile

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 903 8354
Address:
3 Dublin Landings, North Wall Quay, Dublin, Ireland
Amb8675309
Amb8675309 May. 2 at 4:18 AM
$ITRM so either drug manufacturers should give up and continue to use generics that are less & less effective every year or, in the hands of the right BP, with a solid established sales team & cash to cover a proper launch they should wade into the fray & try to get doctors to use something other than a drug that was developed in 1950’s. The solution to rising resistance is not to keep using the same drugs that work less well every year. I encourage you guys to go on Reddit. Look up these Subreddits where women, many of them young, keep posting about repeat uUTIs- Their HCPs keep giving them the same generic on a UTI and they keep getting UTIs and/or infection never clears. so this is not just a problem for older women. BP needs to do better and maybe with Barda & Pasteur act we will finally get good drugs and people will finally give a shit about women’s healthcare. like I said before if this was an erectile dysfunction drug, we would be sold for 1 Bil Nov/2024
1 · Reply
Amb8675309
Amb8675309 May. 2 at 4:10 AM
$ITRM lastly just because there’s a possible revenue stream for using Orly as a med for a cUTI patient leaving the hospital and like another doctor told me as a discharge for a patient leaving the hospital for pneumonia, doesn’t mean that this entire idea of going after the empirically treated/first script written in an outpatient setting isn’t a viable path forward. CF just ran out of money. if there wasn’t any validity in trying to break the stranglehold that cheap generics from the 1950s have on the treatment of uUTIs in a doctor office setting, then why is bluejepa approved and going after generics too? Why did GSK spend all that money to develop an RNA(unproven in the real world) method of killing the pathogen if no HCP is ever going to pivot from using generics? doctors complain about rising resistance from these drugs that have been around too long/used for the wrong indications, but then people are saying that HCPs will never try anything new& simply stick with generics
0 · Reply
Amb8675309
Amb8675309 May. 2 at 4:01 AM
$ITRM plus I took lots of notes in my calls to Alto and there are other people on here that also called Alto and kept a spreadsheet and we were told by multiple different pharmacist that a lot of scripts were being written as in more than seven as in more than 50, I even specifically said I did not want to be a guinea pig and take some medicine. No one else had received, and I said that it would make me feel more comfortable. If I could know that it was specialty big volume clinics to deal with complicated UTIs all the time and they told me that’s who’s writing the scripts. One of the pharmacist even said that that one clinic was writing multiple scripts for different patients so they were obviously in retention rate land using or limbo for different patients that fell into those buckets that I’ve discussed.
0 · Reply
Amb8675309
Amb8675309 May. 2 at 3:59 AM
$ITRM on one of my calls with CF, I asked him if he intended to share weekly script data with us. I pushed him really hard that he needed to communicate better and tell us exactly how the launch is going on a weekly basis. He said he was not going to share weekly script data and I replied, “well can’t someone just get a subscription to Symphony or IQVIA and see how the scripts are going?” and he said not if he doesn’t participate. I thought that was kind of shady, but my husband felt that sometimes you don’t want that information out there, especially if a competitor is about to launch so I’ll reserve judgment on his decision. but he did say multiple times he was not going to share that script data so what the other gentleman who is a doctor posted today- according to my double checking on Claude- is confirming what CF said: if they were using payer coupon coupons and everything else we’re not going to see those scripts and also there’s a time lag for alto filled scripts. 
0 · Reply
Amb8675309
Amb8675309 May. 2 at 3:55 AM
$ITRM F it: it’s been a stressful 18 months so I’m going to lay everything out. You guys can dissect/eviscerate me everything else. Firstly, full disclosure to Yellowjacker: . I took all your posts and I asked Claude to pretend that they were an FBI psychological profiler to see if you are in fact in need of psychiatric meds and they say no. they say you’ve done your homework and that you must have access to some information that we can’t see but you appear to be methodical, convicted and sane. the only ding to your credibility, according to Claude, is the fact that you have made predictions about imminent news “next week” at least 4 times and.. no news yet. That leads me to believe that you’ve done your homework, but you’re also getting some sort of information, whether it’s an inside tip I don’t want to use that word but you’re getting information from somewhere and we have to respect if you don’t want to share it, but Claude says you’re not the mayor of crazy town
1 · Reply
MusketeerQuant
MusketeerQuant May. 1 at 8:37 PM
$ITRM 2026Q1 all payer claims data (Definitive HC, ~60% clearinghouse coverage). Similar output in IQVIA LRx. Will construct monthly trend once we merge additional datasets.
3 · Reply
Steloco1
Steloco1 May. 1 at 8:13 PM
$ITRM great. Not a pill 🤗
0 · Reply
Steloco1
Steloco1 May. 1 at 8:12 PM
$ITRM Fetroja is the brand name for cefiderocol, an advanced IV antibiotic used to treat serious bacterial infections, especially when other antibiotics don’t work. What makes it different Fetroja is often called a “siderophore cephalosporin”—it uses a clever mechanism to enter bacteria by hijacking their iron uptake system (like a “Trojan horse”), which helps it fight hard-to-treat Gram-negative bacteria. What it treats Doctors use it for severe infections such as: Complicated urinary tract infections (cUTIs) Hospital-acquired and ventilator-associated pneumonia Infections caused by multidrug-resistant bacteria (like Pseudomonas, Acinetobacter, etc.) How it’s given Administered intravenously (IV) in a hospital setting Not a pill you take at home
0 · Reply
GatorMcKlusky
GatorMcKlusky May. 1 at 8:10 PM
$ITRM Same as yesterday. Big bids appear late in the day to close the massive bid/ask gap that the MM left open all day. Volume and price shoot up before the close. Let's see if the trend continues and we keep creeping up before we finally get the deal/liquidation results. Luckily it appears there was some interest. Whether it is Shionogi and the 240 billion they are sitting on I don't really know...GOOD GAME GUYS!
1 · Reply
Starbillias
Starbillias May. 1 at 7:14 PM
$ITRM The 482 million awarded to Shionogi from BARDA is to expand Fetroja in the USA. These monies can not be used for other uses. It makes sense they are using some of these funds to expand there sales network.
1 · Reply
Latest News on ITRM
No data available.
Amb8675309
Amb8675309 May. 2 at 4:18 AM
$ITRM so either drug manufacturers should give up and continue to use generics that are less & less effective every year or, in the hands of the right BP, with a solid established sales team & cash to cover a proper launch they should wade into the fray & try to get doctors to use something other than a drug that was developed in 1950’s. The solution to rising resistance is not to keep using the same drugs that work less well every year. I encourage you guys to go on Reddit. Look up these Subreddits where women, many of them young, keep posting about repeat uUTIs- Their HCPs keep giving them the same generic on a UTI and they keep getting UTIs and/or infection never clears. so this is not just a problem for older women. BP needs to do better and maybe with Barda & Pasteur act we will finally get good drugs and people will finally give a shit about women’s healthcare. like I said before if this was an erectile dysfunction drug, we would be sold for 1 Bil Nov/2024
1 · Reply
Amb8675309
Amb8675309 May. 2 at 4:10 AM
$ITRM lastly just because there’s a possible revenue stream for using Orly as a med for a cUTI patient leaving the hospital and like another doctor told me as a discharge for a patient leaving the hospital for pneumonia, doesn’t mean that this entire idea of going after the empirically treated/first script written in an outpatient setting isn’t a viable path forward. CF just ran out of money. if there wasn’t any validity in trying to break the stranglehold that cheap generics from the 1950s have on the treatment of uUTIs in a doctor office setting, then why is bluejepa approved and going after generics too? Why did GSK spend all that money to develop an RNA(unproven in the real world) method of killing the pathogen if no HCP is ever going to pivot from using generics? doctors complain about rising resistance from these drugs that have been around too long/used for the wrong indications, but then people are saying that HCPs will never try anything new& simply stick with generics
0 · Reply
Amb8675309
Amb8675309 May. 2 at 4:01 AM
$ITRM plus I took lots of notes in my calls to Alto and there are other people on here that also called Alto and kept a spreadsheet and we were told by multiple different pharmacist that a lot of scripts were being written as in more than seven as in more than 50, I even specifically said I did not want to be a guinea pig and take some medicine. No one else had received, and I said that it would make me feel more comfortable. If I could know that it was specialty big volume clinics to deal with complicated UTIs all the time and they told me that’s who’s writing the scripts. One of the pharmacist even said that that one clinic was writing multiple scripts for different patients so they were obviously in retention rate land using or limbo for different patients that fell into those buckets that I’ve discussed.
0 · Reply
Amb8675309
Amb8675309 May. 2 at 3:59 AM
$ITRM on one of my calls with CF, I asked him if he intended to share weekly script data with us. I pushed him really hard that he needed to communicate better and tell us exactly how the launch is going on a weekly basis. He said he was not going to share weekly script data and I replied, “well can’t someone just get a subscription to Symphony or IQVIA and see how the scripts are going?” and he said not if he doesn’t participate. I thought that was kind of shady, but my husband felt that sometimes you don’t want that information out there, especially if a competitor is about to launch so I’ll reserve judgment on his decision. but he did say multiple times he was not going to share that script data so what the other gentleman who is a doctor posted today- according to my double checking on Claude- is confirming what CF said: if they were using payer coupon coupons and everything else we’re not going to see those scripts and also there’s a time lag for alto filled scripts. 
0 · Reply
Amb8675309
Amb8675309 May. 2 at 3:55 AM
$ITRM F it: it’s been a stressful 18 months so I’m going to lay everything out. You guys can dissect/eviscerate me everything else. Firstly, full disclosure to Yellowjacker: . I took all your posts and I asked Claude to pretend that they were an FBI psychological profiler to see if you are in fact in need of psychiatric meds and they say no. they say you’ve done your homework and that you must have access to some information that we can’t see but you appear to be methodical, convicted and sane. the only ding to your credibility, according to Claude, is the fact that you have made predictions about imminent news “next week” at least 4 times and.. no news yet. That leads me to believe that you’ve done your homework, but you’re also getting some sort of information, whether it’s an inside tip I don’t want to use that word but you’re getting information from somewhere and we have to respect if you don’t want to share it, but Claude says you’re not the mayor of crazy town
1 · Reply
MusketeerQuant
MusketeerQuant May. 1 at 8:37 PM
$ITRM 2026Q1 all payer claims data (Definitive HC, ~60% clearinghouse coverage). Similar output in IQVIA LRx. Will construct monthly trend once we merge additional datasets.
3 · Reply
Steloco1
Steloco1 May. 1 at 8:13 PM
$ITRM great. Not a pill 🤗
0 · Reply
Steloco1
Steloco1 May. 1 at 8:12 PM
$ITRM Fetroja is the brand name for cefiderocol, an advanced IV antibiotic used to treat serious bacterial infections, especially when other antibiotics don’t work. What makes it different Fetroja is often called a “siderophore cephalosporin”—it uses a clever mechanism to enter bacteria by hijacking their iron uptake system (like a “Trojan horse”), which helps it fight hard-to-treat Gram-negative bacteria. What it treats Doctors use it for severe infections such as: Complicated urinary tract infections (cUTIs) Hospital-acquired and ventilator-associated pneumonia Infections caused by multidrug-resistant bacteria (like Pseudomonas, Acinetobacter, etc.) How it’s given Administered intravenously (IV) in a hospital setting Not a pill you take at home
0 · Reply
GatorMcKlusky
GatorMcKlusky May. 1 at 8:10 PM
$ITRM Same as yesterday. Big bids appear late in the day to close the massive bid/ask gap that the MM left open all day. Volume and price shoot up before the close. Let's see if the trend continues and we keep creeping up before we finally get the deal/liquidation results. Luckily it appears there was some interest. Whether it is Shionogi and the 240 billion they are sitting on I don't really know...GOOD GAME GUYS!
1 · Reply
Starbillias
Starbillias May. 1 at 7:14 PM
$ITRM The 482 million awarded to Shionogi from BARDA is to expand Fetroja in the USA. These monies can not be used for other uses. It makes sense they are using some of these funds to expand there sales network.
1 · Reply
Amb8675309
Amb8675309 May. 1 at 5:43 PM
$ITRM I agree with dollar a day hiring all these people to sling a Covid drug when the number of people even worried about Covid or even thinking that any vaccine will work i.e. conspiracy theorists. I just don’t see paying each of those people 100 grand across the country to sling a Covid drug.
1 · Reply
blackdollarr
blackdollarr May. 1 at 3:15 PM
$ITRM I have received a message from my broker that stock will be liquidated in 30 days, i will be forced to move to other broker
3 · Reply
XX_Capital
XX_Capital May. 1 at 3:08 PM
$ITRM lawd🙏
0 · Reply
Digger22
Digger22 May. 1 at 1:39 PM
$ITRM I’m sorry a “cutting edge therapy” my bad
0 · Reply
Digger22
Digger22 May. 1 at 1:38 PM
$ITRM I found another post about someone hired by them in the Ft Lauderdale area for a “ cutting edge technology”. Must be instructed to use those terms
1 · Reply
Boom54321
Boom54321 May. 1 at 1:36 PM
$ITRM 🚀
0 · Reply
DollerADay
DollerADay May. 1 at 1:09 PM
$ITRM The Primary Care roles being hired (in the sun belt, aged population concentrated, and major cities) coincidentally targe the highest concentration of medicare/geriatric patients in the US of which have the highest rate of resistant UTIs. Ensitrelvir is an antiviral and considered PC but it definitely isn’t cutting edge. Most importantly, the drug has an FDA action (PDUFA) on June 16th 2026 and hiring a massive team with no product with a potential CRL is not possible. This is a Covid drug, and Derek is slotted in old person heavy UTI Tampa Town.
1 · Reply
Digger22
Digger22 May. 1 at 12:24 PM
$ITRM Shionogi is hiring a trainer to educate a sales force to promote Fetroja. It is used for complicated UTI for those who have limited treatment options. Just tossing this out there. Coincidence?
2 · Reply
jemer
jemer May. 1 at 5:34 AM
$ITRM This guy was an Iterum/Orlynvah Sales Rep until a few weeks ago. Check out his new job...
5 · Reply
ScottR89
ScottR89 May. 1 at 2:44 AM
$ITRM I have spent the last few days searching Japanese websites/forums and have found zero mentions of ITRM anywhere. Anyone else tried?? I would think there would be chatter.
0 · Reply
_MarginCall
_MarginCall May. 1 at 2:13 AM
$ITRM curious what everyone’s occupation is? Are any of you full time traders?
3 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket May. 1 at 1:45 AM
$ITRM
1 · Reply